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Abstract
Background:  Several studies have examined the association between mitochondrial DNA
(mtDNA) deletions, in particular the "common" 4977-bp deletion, and human sperm dysfunction,
but have produced contradictory results.
Findings: Here we show that PCR slippage and primer miss-match to nuclear DNA may lead to
overestimates in the frequency of deletions. Our investigation resolves this issue and gives strong
negative correlation between the proportion of the "common" deletion and sperm motility.
Furthermore, for the first time, we present data which reinforce the hypothesis for a negative
correlation between the mtDNA "common" deletion and fertilization efficiency of spermatozoa.
Conclusion: The present analysis resolves several literature inconsistencies and opens the way
for diagnostic use of the "common" deletion as a molecular indicator of sperm fertility potential.
Background
In the past decade more than 200 point mutations have
been identified in human mtDNA and 45 of them proved
to be associated with disease [1]. Also, more than 100
deletions are known to be involved in diseases [2]. In par-
ticular, a 4977-bp deletion has been associated with a
number of pathological phenotypes [3-7]. This deletion,
also found to accumulate during aging [8], has been char-
acterized as the "common" deletion and used as an
mtDNA damage indicator [9]. The 4977-bp deletion
occurs between two 13-bp direct repeats, located at nucle-
otides 8470–8482 and 13447–13459 respectively, and
results in mtDNA molecules (ΔmtDNA4977) that lack all
or part of a 12 gene cluster. Due to the loss of several vital
OXPHOS genes, mtDNA deletions mainly affect high-
energy demanding post-mitotic cells, such as brain, liver
and muscles. Since spermatozoon movement also
requires a great amount of energy, defects in mitochon-
drial respiratory function is assumed to cause a decline in
motility and, consequently, decrease of fertility.
Several studies have examined the correlation of mtDNA
deletions and sperm dysfunction, but have produced con-
tradictory results. Kao et al. [10] observed a negative cor-
relation between presence and proportion of the 4977-bp
deletion and sperm motility. These authors also reported
a significantly higher incidence of the deletion in patients
with asthenospermia, oligozoospermia and primary infer-
tility when compared to normal individuals. In contrast,
later reports have not found a clear association between
the "common" deletion and infertility categorisation of
donors [11,12]. There is also no clear correlation between
multiple deletions and male infertility. Some studies have
found a higher incidence of multiple mtDNA deletions in
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sub-fertile or infertile men [12,13], while other studies
found no such association [14]. These deletions were not
fully characterized, since neither the precise breakpoints
nor the sequence of the amplified products were deter-
mined.
Here we show that the inconsistencies in the literature are
due to technical inaccuracies of used methods, including
primer miss-annealing and PCR slippage. We have
applied an improved PCR assay in 31 samples with nor-
mal and 83 samples with abnormal sperm parameters and
obtained a clear negative correlation between presence of
the "common" deletion and sperm motility.
Methods
Preparation of spermatozoa and extraction of total DNA
Semen samples were kindly provided by "Eugonia-Iatriki
Erevna-IVF unit, Greece" and "Embioiatriki-IVF unit,
Greece" and classified according to World Health Organi-
zation (WHO) criteria [15]. After the semen sample was
liquefied at room temperature, the spermatozoa were frac-
tionated by Percoll™ (Sigma-Aldrich) 45% and 90% gradi-
ent [16]. Spermatozoa were collected from each layer and
washed three times with five volumes of PBS (phosphate
buffer saline; 137 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, 1.8 mM KH2PO4, pH 7.4) to remove percoll. In
order to avoid contamination from other cells (such as
lymphocytes and epithelial cells), the sperm sample was
incubated, prior to DNA extraction, with 50 mM Tris-HCl
buffer (pH 6.8) at 8°C for 20 min [17], a treatment that
does not affect spermatozoa. Spermatozoa were collected
by centrifugation at 1000-g for 5 min. The sperm pellet
was immediately subjected to DNA extraction as
described by Douris et al. [18].
Qualitative and quantitative PCR assays, PCR conditions, 
cloning and sequencing of PCR products
Detection of mtDNA deletion was carried out by PCR
amplification using primers that flank the deleted region
[see Additional file 1]. With these primers, conventional
PCR gives a product only from molecules bearing the
deletion, because the fragment from the normal mtDNA
is too large to be amplified. Normal mtDNA molecules
were detected using a forward primer located within the
deletion (4977Fi) and an external reverse primer. This
method produces a single PCR product when the sample
contains only normal mtDNA and two products if it con-
tains normal and deleted mtDNA molecules. The relative
amounts of deleted and normal mtDNA were calculated
using PCR-based serial dilution method [19] in mixtures
of known proportions of deleted and normal mtDNA [see
Additional file]. PCR reactions were carried out in a 25-μl
reaction mixture containing 200 μM of each dNTP, 0.5
μM of each primer, 1 unit of Taq  DNA polymerase
(Promega), 1.5–2 mM MgCl2, and 1×reaction buffer (pro-
vided by the company). Cycling conditions were: initial
denaturation at 94°C for 2 min, followed by 25–30 cycles
of denaturation at 94°C for 30 sec, annealing at 55°C to
63°C (depending on the primer pair) for 45 sec and
extension at 72°C for 30–60 sec. Long PCR reactions were
performed with primers Fvelo and Rvelo, or D6 and R10
[see Additional file] in a number of samples, the obtained
products were separated in agarose gels and the appropri-
ate bands were excised and purified using the PureLink
Quick Gel Extraction Kit (Invitrogen), and either cloned
or directly sequenced using a commercial outlet. Long
PCR products produced from four different semen sam-
ples with primers D6 and R10 were subjected to southern
blot analysis [see Additional file 1].
Statistical analysis
Results were analyzed by the pair-wise Chi-square test of
independence or, when the expected numbers are small
(less than five), by Fisher's exact test of independence.
Results and discussion
We tested 53 samples with normal and 96 samples with
abnormal sperm parameters using the primer-shift PCR
assay with previously published primer sets. We obtained
a negative correlation between occurrence of the deletion
and the size of the deletion product (r = -0.978, P = 0.021,
Table 1). A similar observation was reported previously
[20] suggesting that the larger fragments may lead to
underestimation of the deletion occurrence, because they
are less likely to be detected than the smaller fragments
(Figure 1A). We conclude that the literature differences
could be due to the different primer sets used.
This hypothesis led us to the use of primers 4977F and
4977Rc, which produce the smallest deletion-specific
fragment. PCR analysis in 61 of 149 samples revealed a
larger product, in addition to the product expected from
the presence of the "common" deletion, an observation
that suggests the existence of a new deletion (Figure 1B).
Isolation, cloning and sequencing of this PCR product
showed that it corresponds to a region of the human chro-
mosome 11 [see Additional file]. Similar by-products
could also be produced by long PCR, as revealed by south-
ern blot and sequencing [see Additional file]. Given that
such by-products, which may easily result from the use of
small primers, could be mistaken as deletions, is impera-
tive to confirm the presence of any newly deletion-like
product by sequencing. This is particularly so when using
long-PCR for detection of multiple deletions, because it is
customary to assume that all amplified products corre-
spond to mtDNA deletions. We eliminated the miss-
annealing by increasing primer size (Figure 1B). The new
primer set (4977Fx/4977Rcx) also improved the sensitiv-
ity of the detection, since high melting point primers
allow the use of large template amounts, which in turnBMC Research Notes 2009, 2:18 http://www.biomedcentral.com/1756-0500/2/18
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Agarose gel electrophoresis of PCR products Figure 1
Agarose gel electrophoresis of PCR products. (A) Agarose gel electrophoresis of PCR products obtained by using four 
different primer sets in one of the examined semen samples. Lane M: 100-bp marker (Invitrogen, USA); lane 1: 380-bp PCR 
product (primers 4977F and 4977Rc); lane 2: 454-bp PCR product (primers 4977F and 4977R); lane 3: 524-bp PCR product 
(primers 4977F and 4977RK2); lane 4: 719-bp PCR product (primers 4977F and 4977RK3). Equal amount of each PCR reaction 
has been loaded to lanes 1 to 4. (B) Agarose gel electrophoresis of PCR products amplified from three different samples (1–3) 
with primers 4977F/4977Rc (lanes 1a, 2a, 3a) or 4977Fx/4977Rcx (lanes 1b, 2b, 3b). Lane M: 100-bp marker (Invitrogen, USA). 
Amplification with primers 4977F/4977Rc gave two products: a 380 bp band corresponding to ΔmtDNA4977 molecules (lanes 
1a and 2a) and a ~470 bp band proved to be a by-product (lanes 2a and 2b). Specially designed primers 4977Fx/4977Rcx failed 
to produce the ~470 bp by-product (lanes 2b and 3b).
380 bp
454 bp
719 bp
524 bp
M 1234
~380 bp
M 1a 2a 2b 3a 3b
~4 0 bp 7
1b
AB
Table 1: Occurrence of "common" deletion in human spermatozoa using different primer sets
Occurrence of deletion
# Primer set Product size Our dataa Literature data
1 4977F – 4977Rc 380 bp 58.39% (87/149) 53.12% (34/64)b
2 4977F – 4977R 454 bp 42.95% (64/149) 56.55% (15/27)c
3 4977F – 4977RK2 524 bp 34.89% (52/149) 37.5% (15/40)d
4 4977F – 4977RK3 719 bp 17.45% (26/149) Not available
a PCR in 45% percoll fraction
b PCR in non percoll fractionated sperm [11].
c nested PCR with reverse primer MT13 [see supplementary Table 1 of Additional file] in 45% percoll fraction [12].
d PCR in 50% percoll fraction [10].
Chi-square test between our data and the data from the literature gives P = 0.477 for primer set #1, P = 0.226 for primer set #2, and P = 0.760 for 
primer set #3BMC Research Notes 2009, 2:18 http://www.biomedcentral.com/1756-0500/2/18
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allows the detection of deletions represent in low propor-
tions [21].
To examine the possibility that the "common" deletion
could be formed artificially as a result of repeated
sequences [22-25], we used a cloned ~7 kb mtDNA frag-
ment as template that did not contain the deletion
("intact" reference template, see Additional file) in
primer-shift PCR reactions. These reactions gave a dele-
tion-specific product, whose length depended on the
primer set used. This result shows that a deletion-like PCR
product does not necessarily signify the presence of a dele-
tion. We assume that the pseudo-deletion (ψ-deletion)
resulted from PCR-slippage. PCR analysis in a serially
diluted sample of the "intact" mtDNA showed that the
normal product was obtained for rather high dilutions of
the "intact" mtDNA compared to the ψ-deletion product
[see Additional file]. The ratio of the higher dilution that
allows the amplification of the ψ-deletion and of the
higher dilution that allows the amplification of the nor-
mal product (Id/In) was 0.0013 (see "reference table",
Table 2 of Additional file). This value of Id/In is the thresh-
old below which the deletion-specific product would not
indicate presence of the deletion in the mtDNA of a sam-
ple.
Sperm classification, fertilization outcome and proportion 
of the 4977 bp deletion
We first determined the occurrence of the deletion in 31
semen samples with normal ("normal" group) and 83
samples with at least one abnormal sperm characteristic
("defective" group). In many samples a deletion-specific
product was detected, but the Id/In ratio was below the
threshold of 0.0013 (in "normal" samples 36.84% and
30% of the deletion-positives for the 45% and 90% per-
coll fraction respectively, while in "defective" samples
4.16% and 0% for the 45% and 90% percoll fraction
respectively). These samples are either false positives or
their deletion proportion is lower than the resolution of
the detection method. These findings point out that a sig-
nificant number of samples, especially from "normal"
donors, could be mistakenly considered as bearing the
deletion.
Our results (Table 2) revealed a clear correlation between
percoll fraction and occurrence of the "common" dele-
tion, which was stronger in the "defective" group (Chi
square test of independence, P = 0.003 and P = 0.0008,
respectively). On the other hand, the frequency of occur-
rence of the 4977-bp deletion did not differ significantly
between "normal" and "defective" groups (in both percoll
fractions). Fisher's test did not reveal a significant differ-
ence between the "normal" group and any of the 7 "defec-
tive" subgroups (P > 0.05). These results indicate that the
deletion is detected more often in spermatozoa with low
motility, an observation that concurs with the findings of
Kao et al. [10]. Also, no statistically significant correlation
was revealed between the occurrence of the "common"
deletion and sperm classification (in both percoll frac-
tions). These findings are in broad agreement with the
studies of Cummins et al. [11] and John et al. [12], but
contradict the results of Kao et al. [10] who reported a
higher incidence of the "common" deletion in men with
oligoasthenozoospermia. This might be due to the
extremely small number of examined oligoastheno-
zoospermic samples in the report of Kao et al. [10] (one
man with oligozoospermia and one with asthenozoosper-
mia). The same authors reported a negative correlation
between presence of the "common" deletion and primary
infertility. Primary or secondary infertility could be due to
a number of causes that do not necessarily affect sperm
characteristics [26]. Attempts to correlate mtDNA dele-
tions with sperm characteristics must include a significant
number of semen samples, strictly classified according to
their sperm parameters.
Regarding the proportion of the "common" deletion, our
results indicate that the majority of men with normal
sperm parameters carried fewer ΔmtDNA4977 molecules
compared to the "defective" group (P = 0.04) (Table 2 and
Figure 2A, B). Fisher's exact test of independence also
revealed that men with asthenozoospermia, asthenotera-
tozoospermia and oligoasthenoteratozoospermia carried
more  ΔmtDNA4977 molecules compared to "normal"
individuals (P = 0.004).
According to WHO criteria, a "normal" semen sample
could carry a number of spermatozoa with abnormal
parameters, such us low motility or abnormal morphol-
ogy. Fractionation of spermatozoa in percoll gradients
separates the highly motile and morphologically normal
spermatozoa [27,28], and under this explains the signifi-
cantly higher occurrence of the deletion in the "low-motil-
ity" 45% fraction compared to the "high-motility" 90%
fraction. Also, since the majority of spermatozoa with low
motility, from "normal" or "defective" samples, congre-
gate in the 45% fraction, we may explain the absence of a
statistically significant difference in the occurrence of the
deletion in this fraction between "normal" and "defec-
tive" samples. The same conclusion holds for the 90%
fraction. Finally, our observation that "defective" samples
bear a higher proportion of deleted molecules can be
explained by the fact that "defective" samples carry more
abnormal spermatozoa than the "normal" group.
Combining these findings with the observation that
asthenozoospermic, asthenoteratozoospermic and oli-
goasthenoteratozoospermic men carried more
ΔmtDNA4977 molecules, we conclude that there is a cor-
relation between sperm motility, but there is no such cor-BMC Research Notes 2009, 2:18 http://www.biomedcentral.com/1756-0500/2/18
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relation with morphology or sperm count, or with the
proportion of the deletion. This could be explained under
the assumption that mtDNA defects would primarily
affect energy production and, thus, movement of sperma-
tozoa.
From the 67 patients which underwent IVF or ICSI treat-
ment, 14 had low fertility rates (<25%). Fisher's test
revealed a significant correlation between the proportion
of the "common" deletion in the 90% percoll fraction,
and low fertilization rates after IVF (Figure 2C, D). Specif-
ically, 75% of men that had a deletion proportion above
Table 2: Proportion of the "common" deletion in 45% and 90% percoll fraction of semen samples
Proportion of deletionb
Percoll fraction Sperm classificationa Number of samples 10% – 1% 1% – 0.1% <0.1% 0%c
31 1 (3.22%) 8 (25.81%) 3(9.68%) 19 (61.29%)
Defected A 10 5 (50%) 1 (10%) 0 (0%) 4 (40%)
A 11 2 (18.18%) 4 (36.36%) 0 (0%) 5 (45.45%)
T 5 0 (0%) 1 (20%) 0 (0%) 4 (80%)
AT 20 8 (40%) 3 (15%) 0 (0%) 9 (45%)
OA 7 2 (28.57%) 2 (28.57%) 0 (0%) 3 (42.85%)
OT 5 0 (0%) 1 (20%) 1 (20%) 3 (60%)
OAT 25 12 (48%) 2 (8%) 2 (8%) 9 (36%)
Total 83 29 (34.93%) 14 (16.86%) 3 (3.61%) 37 (44.58%)
Total 114 30 (26.32%) 22 (19.3%) 6(5.26%) 56 (49.12%)
90% Normal 28 0 (0%) 4 (14.29%) 3 (10.71%) 21 (75%)
Defected A 7 1 (14.28%) 0 (0%) 0 (0%) 6 (85.71%)
T 7 0 (0%) 2 (28.57%) 0 (0%) 5 (71.42%)
O0 - - - -
AT 11 1 (9.09%) 1 (9.09%) 0 (0%) 9 (81.81%)
OA 2 0 (0%) 1 (50%) 0 (0%) 1 (50%)
OT 0 - - - -
OAT 12 3 (25%) 0 (0%) 0 (0%) 9 (75%)
Total 39 5 (12.82%) 4 (10.25%) 0 (0%) 30 (76.92%)
Total 67 5 (7.46%) 8 (11.94%) 3 (4.48%) 51 (76.12%)
a A, Asthenozoospermic; T, Teratozoospermic; O, Oligozoospermic; AT: Asthenoteratozoospermic; OA: Oligoasthenozoospermic; OT: 
Oligoteratozoospermic; OAT: Oligoastenoteratozoospermic
b Determined according to supplementary Table 2 [see Additional file].
c No deletion-specific product was detected, or the detected deletion-specific product represents pseudo-deletion (Id/In ≤ 0.0013).
Samples were categorized in two groups based on their sperm parameters. "normal" group includes samples with normal parameters while 
"defected" group samples with at least one abnormal parameter (according to WHO criteria).BMC Research Notes 2009, 2:18 http://www.biomedcentral.com/1756-0500/2/18
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0.1% showed a low fertilization rate, in contrast to
15.64% with a deletion proportion below 0.1% (P  =
0.0026). Nevertheless, no correlation was obtained
between this parameter and fertilization rate in ICSI
patients (P = 0.47). In IVF cases, sperm is selected by nat-
ural barriers, which means that spermatozoa with signifi-
cant numbers of ΔmtDNA4977 molecules do not produce
enough energy for their movement and thus oocyte ferti-
lization is less likely to occur. ICSI, however, bypasses this
natural selection process and allows fertilization by sper-
Comparison of the "common" deletion and semen quality and fertilization ability Figure 2
Comparison of the "common" deletion and semen quality and fertilization ability. (A-B) Comparison of the inci-
dence of the "common" deletion in 45% and 90% percoll fraction from "normal" (A) and "defected" (B) semen samples. Samples 
were classified in four groups according to the calculated proportion of the deletion (see Additional file). (C-D) Comparison of 
the fertilization rate after IVF (C) and ICSI (D) from patients with different proportion of the "common" deletion. Samples 
were classified in two groups according to the calculated proportion of the deletion (above or below 0.1%).
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matozoa with low energy production. No statistically sig-
nificant difference was detected between deletion
proportion and pregnancy or delivery rates per transfer,
after either IVF or ICSI. In other words our observations
could imply that the load of common deletion in a semen
sample reduces male fertility affecting mainly the fertiliza-
tion efficiency of spermatozoa rather than affecting
embryonic development. These results suggest, for the
first time, a correlation between mtDNA integrity and fer-
tilization efficiency of spermatozoa. In vivo studies in
transmitochondrial mouse also underline the essential
role of mitochondrial respiratory in mammalian sperma-
togenesis and demonstrate that mtDNA defects are
responsible for male infertility [29].
The power of semen parameter analysis in predicting
future fertility is questioned in the past few years [30]. Yet,
new molecular tests, based on measurements of sperm
DNA quality, aim at the successful treatment of male
infertile patients. The mitochondrial genome of sperm
has also been proposed as a marker of sperm health. Our
investigation resolves several literature inconsistencies
and points to a way for the construction of a molecular
test for the estimation of sperm integrity and fertility
potential, even in cases of idiopathic infertility.
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